May 6 |
Vertex Pharmaceuticals Q1 2024 Earnings: Surpasses Revenue Expectations with Strategic Expansions
|
May 6 |
Vertex provides another EPS beat as net income rises 56% in Q1
|
May 6 |
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
|
May 6 |
Vertex Beats Quarterly Forecasts, But Its Pipeline Remains Key
|
May 6 |
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments
|
May 6 |
Vertex Pharmaceuticals Non-GAAP EPS of $4.76 beats by $0.70, revenue of $2.69B beats by $110M
|
May 6 |
Vertex Reports First Quarter 2024 Financial Results
|
May 6 |
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
|
May 5 |
3 No-Brainer Stocks to Buy in May
|
May 5 |
Wall Street Breakfast: The Week Ahead
|